Clik here to view.
Oramed to dual-list on Tel Aviv exchange
Oramed Pharmaceuticals (NSDQ:ORMP) said today that it won approval from the Israel Securities Authority to dual-list its common stock on the Tel Aviv Stock Exchange. Stock in the Jerusalem-based...
View ArticleClik here to view.
Novo Nordisk recalls cartridge holders in insulin delivery devices
Novo Nordisk (NYSE:NVO) launched a recall yesterday of insulin cartridge holders used in select batches of NovoPen Echo insulin delivery devices. The company said the cartridge holders could crack or...
View ArticleClik here to view.
Eli Lilly pledges up to $52m to Purdue for improving injection tech
Eli Lilly (NYSE:LLY) said today that it pledged up to $52 million to Purdue University as part of a 5-year research agreement. The deal is Purdue’s largest strategic collaboration with a single...
View ArticleClik here to view.
Delcath raises $2m in Series B stock sale
Delcath Systems (NSDQ:DCTH) has raised $2 million after selling 2,360 shares of Series B preferred stock at $1,000 per share to unnamed institutional investors, according to a regulatory filing. The...
View ArticleClik here to view.
Google backs Decibel Therapeutics in big data hearing loss play
Decibel Therapeutics said today it landed an investment from GV, formerly Google Ventures. GV agreed to make an equity investment in the Boston-based company and lend its capabilities in big data...
View ArticleClik here to view.
Endo pulls painkiller from the market following FDA request
Endo Pharmaceuticals (NSDQ:ENDP) said today that it will voluntarily pull its Opana ER painkiller from the market. The move comes just weeks after the FDA asked the company to pull the plug on its...
View ArticleClik here to view.
Researchers develop light-sensitive hydrogel for controlled drug delivery
Researchers at the Hong Kong University of Science and Technology have developed a light-sensitive hydrogel that could be useful for drug delivery. Conventional materials for hydrogel scaffolds include...
View ArticleClik here to view.
Capillary Biomedical takes aim at ‘the Achilles heel of diabetes’
Major players in the medical device realm are in a heated race to develop the first artificial pancreas to help patients with diabetes manage the chronic condition. Just last year, Medtronic...
View ArticleClik here to view.
Pacira halts DepoCyt production over manufacturing issue
Pacira Pharmaceuticals (NSDQ:PCRX) said late last month that it plans to stop producing its liposomal chemotherapeutic due to “persistent technical issues specific to the DepoCyt(e) manufacturing...
View ArticleClik here to view.
Resolute Onyx drug-eluting stent launches in Japan
Medtronic (NYSE:MDT) said this week that it’s Resolute Onyx drug-eluting stent will launch in Japan on July 10th. The device’s predecessor, Resolute Integrity, began selling in Japan in August 2012....
View ArticleClik here to view.
FDA clears first new sickle cell treatment in 20 years
Emmaus Life Sciences said last week that the FDA approved its L-glutamine oral powder, Endari, as a therapy to lessen the complications of sickle cell disease in patients ages 5 and older. The drug’s...
View ArticleClik here to view.
Ocular Therapeutix faces more manufacturing problems as FDA decision deadline...
Shares in Ocular Therapeutix (NSDQ:OCUL) fell last week after the company revealed that it received another letter from the FDA about issues spotted by the regulatory agency during a pre-approval...
View ArticleClik here to view.
Inotek recalibrates after drug fails in glaucoma trial
Inotek Pharmaceuticals (NSDQ:ITEK) said last week that its glaucoma drug failed in a Phase II trial. This marks the 2nd problem for Inotek’s drug this year, after it failed in a late-stage trial...
View ArticleClik here to view.
Defymed reveals development of novel insulin delivery device
France-based medtech company Defymed said today that it’s developing a novel insulin delivery device which it hopes to bring to market by the end of 2020. The company’s device, ExOlin, uses a...
View ArticleClik here to view.
Study: Dangerous medication errors are on the rise
According to a study published in Clinical Toxicology, researchers from Nationwide Children’s Hospital found there was a 100% increase in the rate of serious medication errors per 100,000 U.S....
View ArticleClik here to view.
Ocular seeks to extend regulatory timeline for Dextenza due to manufacturing...
Ocular Therapeutix (NSDQ:OCUL) said today that it submitted details of a manufacturing equipment change as an amendment to the new drug application resubmission for Dextenza, the company’s...
View ArticleClik here to view.
pSivida licenses European rights for Durasert to Alimera
pSivida (NSDQ:PSDV) said today that it restructured a deal with Alimera Sciences (NSDQ:ALIM) to grant Alimera rights to the Durasert three-year treatment for posterior segment uveitis in Europe, the...
View ArticleClik here to view.
Oramed to meet with FDA about late-stage clinical program for oral insulin...
Oramed Pharmaceuticals (NSDQ:ORMP) said today that the FDA scheduled an end-of-phase II meeting with the Jerusalem-based company for August 31. Oramed is developing an oral insulin capsule for the...
View ArticleClik here to view.
Generic drug trade association sues over Maryland’s price gouging law
In June, Maryland became the 1st state to pass a law in an attempt to ban price gouging by generic pharmaceutical manufacturers. The bill passed without the governor’s signature, who took issue with...
View ArticleClik here to view.
Equashield seeks to automate hazardous drug handling: a Drug Delivery...
Equashield’s Jason Dutcher chats with Drug Delivery Business Newseditor Sarah Faulkner about the company’s closed system transfer device and its latest move to automate hazardous drug compounding....
View Article